Recent Zocdoc analytics reveal that patients who book an initial GLP‑1 consultation are 21% more likely to schedule further medical appointments over the next year than the platform’s typical users. This uptick suggests that the medication is not only helping people lose weight, but also encouraging them to re‑engage with the health‑care system.
More Visits, More Coordination
After an initial GLP‑1 visit, 42.6% of patients also booked a primary‑care appointment within the following twelve months—more than double the rate for average Zocdoc users. Physicians report that the drug’s effects require ongoing monitoring, dose adjustments, and management of early gastrointestinal side effects such as nausea, acid reflux, constipation and diarrhea.
“A GLP‑1 is not a static, ‘set‑it‑and‑forget‑it’ prescription,” said Dr. Amy Sheer, an obesity‑medicine specialist at the University of Florida. “Prescribing these medications requires active, ongoing medical monitoring. You’re tailoring doses, managing side effects, and continually adjusting care to the individual patient.”
Managing Early Side Effects
Australian researchers earlier this year reported that nearly 43% of new GLP‑1 patients who had never taken symptom‑relief drugs required a secondary prescription to address early side effects. Importantly, these additional prescriptions did not increase emergency‑room visits or hospitalizations; most issues were resolved in routine outpatient visits.
Dr. Jonathan Bonnet, chief medical officer at the Ardmore Institute of Health, explained, “If they have side effects, we have to manage those side effects. We decide whether to treat symptomatically, adjust the dose, or stop the medication.”
Weight Loss Opens a Clinical Window
When patients lose 10%‑20% of their body weight, blood pressure often drops and glycemic control improves, prompting clinicians to reassess long‑standing medications. Dr. Bonnet noted that proactive deprescribing is essential to avoid over‑medication.
Joe Coe, who has been on a GLP‑1 for almost a year, described how his weight loss motivated him to address other health concerns. “I took my migraines more seriously after I lost weight,” he said. “If I want to keep the weight off, I need to stay healthy in other areas of my life.”
Integrating Nutrition and Mental Health
Because GLP‑1s can reduce both fat and lean muscle mass, Dr. Sheer’s team connects patients with registered dietitians, physical therapists and fitness programs that emphasize resistance training and high‑protein nutrition. Patients are also screened for mood and body‑image changes, with many receiving mental‑health support for anxiety, depression or ADHD.
Elissa Drassinower, a four‑year GLP‑1 user who lost more than 50 pounds, praised the collaborative approach. “My doctor is very accessible through the portal, and getting quick answers has brought me closer to my doctor,” she said.
What This Means for Patients and Providers
The data suggest that GLP‑1 prescriptions create an opportunity for sustained, partnership‑based care rather than isolated, episodic visits. Providers report that handling the medication’s side‑effect profile requires dedicated staff, such as triage nurses, to field frequent patient inquiries.
Dr. Bonnet warned against viewing the drug as a short‑term fix. “Weight often returns when treatment stops, so starting a GLP‑1 is typically an ongoing commitment.” He added that when patients see the medication as a tool for overall health, they are more likely to adopt lasting lifestyle changes.
Overall, the emerging pattern shows that GLP‑1 therapy is reshaping how patients interact with their health‑care teams, fostering a more holistic, continuous approach that benefits weight management, chronic‑disease control, nutrition, and mental well‑being.
Original reporting: El Paso News (HLL/CB) — read the source article.
